Search filters

List of works by Sven Skog

A Chemiluminescent Protein Microarray Method for Determining the Seroglycoid Fucosylation Index

scientific article published on 16 August 2016

A meta-analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment

scientific article published on 25 February 2020

Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression.

scientific article

Extracellular 8-oxo-dG as a sensitive parameter for oxidative stress in vivo and in vitro

scientific article

Hadrontherapy Interactions in Molecular and Cellular Biology

scientific article published on 24 December 2019

High thymidine kinase 1 (TK1) expression is a predictor of poor survival in patients with pT1 of lung adenocarcinoma

scientific article published on December 6, 2011

Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix

scientific article

Serological TK1 predict pre-cancer in a routine health screenings of 56,178 people

scientific article published on 6 April 2018

Serological thymidine kinase 1 (STK1) indicates an elevated risk for the development of malignant tumours

scientific article published in November 2008

Serological thymidine kinase 1 is a biomarker for early detection of tumours--a health screening study on 35,365 people, using a sensitive chemiluminescent dot blot assay

scientific article

Serological thymidine kinase 1 is a prognostic factor in oesophageal, cardial and lung carcinomas

scientific article published in July 2010

Serum 8-Oxo-dG as a Predictor of Sensitivity and Outcome of Radiotherapy and Chemotherapy of Upper Gastrointestinal Tumours.

scientific article

Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people

scientific article

Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin's lymphoma patients

scientific article published on 7 February 2010

Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings

scientific article published in April 2010

Serum thymidine kinase 1 is a reliable maker for the assessment of the risk of developing malignancy: A case report

scientific article

Serum thymidine kinase 1 is associated with Gleason score of patients with prostate carcinoma

Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer

scientific article

Serum thymidine kinase 1 reflects the progression of pre-malignant and malignant tumors during therapy

scientific article published on September 1, 2008

The Half-Life of Serum Thymidine Kinase 1 Concentration Is an Important Tool for Monitoring Surgical Response in Patients with Lung Cancer: A Meta-Analysis

scientific article

The proliferation marker thymidine kinase 1 in clinical use

scientific article published on 4 September 2012

The proliferation marker thymidine kinase 1 level is high in normal kidney tubule cells compared to other normal and malignant renal cells

scientific article published on 3 December 2009

Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: A useful tool in tumor therapy management

scientific article published on November 2009

Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker

scientific article published in June 2017

Thymidine kinase 1 is a better prognostic marker than Ki-67 for pT1 adenocarcinoma of the lung.

scientific article

Thymidine kinase activity in serum of renal cell carcinoma patients is a useful prognostic marker

scientific article published in June 2009

Transient increase in serum thymidine kinase 1 within one week after surgery of patients with carcinoma.

scientific article published in April 2010